Quantum Biopharma Ltd. | WebDisclosure

Basculer en Français

8604	Companies
141046	Keywords
76972	Articles
75369	Press releases

Headlines Articles Press releases Quantum Biopharma Ltd.

Home
Companies
Quantum Biopharma Ltd.

PRESS RELEASE

published on 09/07/2024 at 01:30, 7 months 2 days ago

Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Quantum BioPharma announces Nasdaq compliance and completion of debt settlements with executives. Initiates Class A Share offering. Grants options and RSUs. Cancels warrants and gives forward-looking information

Nasdaq Compliance Debt Settlements Class A Shares Forward-looking Information Quantum BioPharma
BRIEF

published on 08/30/2024 at 13:35, 7 months 9 days ago

Quantum BioPharma lance unbuzzd™ sur Amazon

Unbuzzd™ Biopharmacie Quantique Guérison De L'alcoolisme Lancement D'Amazon Nutrition Cellulaire
BRIEF

published on 08/30/2024 at 13:35, 7 months 9 days ago

Quantum BioPharma Launches unbuzzd™ on Amazon

Unbuzzd™ Celly Nutrition Alcohol Recovery Quantum BioPharma Amazon Launch
PRESS RELEASE

published on 08/30/2024 at 13:30, 7 months 9 days ago

Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT"
Quantum BioPharma announces the launch of unbuzzd™ Clear Eyed Citrus Powder Sticks, a product designed to help with alcohol recovery and focus on what's next. Celly Nutrition Corp partners debut this groundbreaking solution on Amazon.com

Alcohol Recovery Unbuzzd Celly Nutrition Corp Quantum BioPharma Amazon.com
BRIEF

published on 08/24/2024 at 01:35, 7 months 16 days ago

Quantum Biopharma Announces Management Changes and Debt Settlement Plans

Debt Settlement Restricted Share Units Management Changes Quantum BioPharma Option Cancellation
BRIEF

published on 08/24/2024 at 01:35, 7 months 16 days ago

Quantum Biopharma annonce des changements de direction et des plans de règlement de la dette

Changements De Direction Unités D'actions Restreintes Biopharmacie Quantique Règlement De Dette Annulation D'option
PRESS RELEASE

published on 08/24/2024 at 01:30, 7 months 16 days ago

Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
Quantum BioPharma announces management changes, option cancellation, RSU grant, debt settlement, and related party transaction. Details on new roles and financial updates

Debt Settlement Financial Updates Related Party Transaction Management Changes Quantum BioPharma

Accesswire

Published on 04/09/2025 at 09:00, 1 hour 5 minutes ago

Touchstone Exploration Announces Changes to Its Board of Directors
Published on 04/09/2025 at 08:00, 2 hours 5 minutes ago

Ondine Biomedical Inc. - Economic Study Suggests c.£200 Million UK Savings
Published on 04/09/2025 at 07:40, 2 hours 25 minutes ago

RTG Mining Inc. Announces Issue Of A$4.2 million Chess Depository Instruments Under Placement
Published on 04/09/2025 at 04:00, 6 hours 5 minutes ago

QNX Now Powering WeRide's Next-Generation ADAS Platform
Published on 04/08/2025 at 22:47, 11 hours 18 minutes ago

MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025

View all ACCESSWIRE

EQS Group

Published on 04/09/2025 at 09:37, 27 minutes ago

Partec AG: ParTec AG announces major participation in advancing Europe’s Digital Autonomy in HPC and AI with the DARE SGA1 Project
Published on 04/09/2025 at 09:24, 41 minutes ago

H&R GmbH & Co. KGaA publishes Annual Report and Sustainability Report for FY 2024
Published on 04/09/2025 at 09:06, 58 minutes ago

EQS-Adhoc: swissnet Group announces delisting of its shares from Euronext Access+ Paris
Published on 04/09/2025 at 09:05, 1 hour ago

More Impact AG introduces Z-Boxx as an innovative smoking cessation product
Published on 04/09/2025 at 09:00, 1 hour 4 minutes ago

Original-Research: Multitude SE (von NuWays AG): BUY

Les Echos

Published on 04/09/2025 at 09:00, 1 hour 5 minutes ago

STEF : Avis de mise à disposition des comptes annuels 2024
Published on 04/09/2025 at 08:00, 2 hours 5 minutes ago

Museum Studio becomes a majority shareholder in Lord Cultural Resources
Published on 04/09/2025 at 08:00, 2 hours 5 minutes ago

Museum Studio devient actionnaire majoritaire de Lord Cultural Resources
Published on 04/09/2025 at 07:00, 3 hours 5 minutes ago

Biophytis confirme le lancement de l’essai clinique de Phase 2 OBA dans l’obésité
Published on 04/09/2025 at 07:00, 3 hours 5 minutes ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity

View all LES ECHOS COMFI WIRE